7771 - 7780 of 7915 Results
Title
Year
-
OPENTitle: Evaluation of D2 and D3 dopamine receptor selective compounds on l-dopa-dependent abnormal involuntary movements in ratsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 56Issue #: 6-7Start Page: 956End Page: 969Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2009.01.019Best OA location URL: https://europepmc.org/articles/pmc4106465?pdf=renderCitation Count: 53
-
OPENTitle: Evaluation of the D3 dopamine receptor selective antagonist PG01037 on l-dopa-dependent abnormal involuntary movements in ratsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 56Issue #: 6-7Start Page: 944End Page: 955Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2009.01.020Best OA location URL: https://europepmc.org/articles/pmc3820009?pdf=renderCitation Count: 46
- Expression and localization of lactotransferrin messenger RNA in the cortex of Alzheimer's disease2009OPENTitle: Expression and localization of lactotransferrin messenger RNA in the cortex of Alzheimer's diseaseJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 452Issue #: 3Start Page: 277End Page: 280Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2009.01.071Best OA location URL: https://europepmc.org/articles/pmc2667624?pdf=renderCitation Count: 31
-
OPENTitle: α-Synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicityJournal Name: Nature GeneticsPublisher: Springer Science and Business Media LLCVol: 41Issue #: 3Start Page: 308End Page: 315Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/ng.300Best OA location URL: https://europepmc.org/articles/pmc2683786?pdf=renderCitation Count: 520
-
OPENTitle: Evidence that DmMANF is an invertebrate neurotrophic factor supporting dopaminergic neuronsJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 106Issue #: 7Start Page: 2429End Page: 2434Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.0810996106Best OA location URL: https://europepmc.org/articles/pmc2650173?pdf=renderCitation Count: 136
-
OPENTitle: FGF20 and Parkinson's disease: No evidence of association or pathogenicity via α‐synuclein expressionJournal Name: Movement DisordersPublisher: WileyVol: 24Issue #: 3Start Page: 455End Page: 459Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22442Best OA location URL: https://europepmc.org/articles/pmc2875476?pdf=renderCitation Count: 43
-
OPENTitle: Funding of Parkinson research from industry and US federal and foundation sourcesJournal Name: Movement DisordersPublisher: WileyVol: 24Issue #: 5Start Page: 731End Page: 737Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22446Best OA location URL: http://ecommons.library.cornell.edu/bitstream/1813/15097/2/Nicholson 09 pub 02.pdfCitation Count: 6
-
OPENTitle: Future of cell and gene therapies for Parkinson's diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 64Issue #: S2Start Page: S122End Page: S138Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.21473Best OA location URL: https://europepmc.org/articles/pmc3982797?pdf=renderCitation Count: 53
-
OPENTitle: Alzheimer Research Forum Live Discussion: Mice on Trial? Issues in the Design of Drug StudiesJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 16Issue #: 1Start Page: 197End Page: 205Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jad-2009-0961Best OA location URL: https://content.iospress.com:443/download/journal-of-alzheimers-disease/jad00961?id=journal-of-alzheimers-disease%2Fjad00961Citation Count: 1
-
OPENTitle: Expression of inflammatory genes induced by beta-amyloid peptides in human brain endothelial cells and in Alzheimer's brain is mediated by the JNK-AP1 signaling pathwayJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 34Issue #: 1Start Page: 95End Page: 106Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2008.12.007Best OA location URL: https://europepmc.org/articles/pmc2720310?pdf=renderCitation Count: 210